Halozyme completes follow-on

Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine, Cancer, Dermatology Date completed: 9/9/10 Type: Follow-on Raised: $62.3 million Shares: 8.3 million Price: $7.50 Share...